newsfilter
← Latest News
PR Newswire·

Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately

  • A class action lawsuit was filed on October 14, 2026, against Hims & Hers Health, Inc. (NYSE: HIMS) by Wolf Haldenstein Adler Freeman & Herz LLP.
  • The class period for eligible investors covers shares purchased between August 4, 2025, and July 29, 2026.
  • The lead plaintiff deadline for the case is November 2, 2026.
  • The complaint alleges the company shared consumer health information with third-party advertising platforms like Meta & Snap.
  • The lawsuit claims the company charged consumers for prescriptions immediately after intake forms despite promising consultations with medical providers.
  • Defendants are accused of failing to disclose material adverse facts, including regulatory scrutiny & the likelihood of incurring fees & penalties.
  • On July 29, 2026, the FTC, California, & Utah authorities sued Hims & Hers for similar allegations regarding subscription cancellations & privacy.
  • Following the regulatory action, Hims & Hers stock fell $4.32 per share, or 14.73%, to close at $25.00 on July 29, 2026.
  • The law firm offers free consultation to affected investors with no cost or obligation to speak with an attorney.